On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).